Literature DB >> 3186994

MR staging of bladder carcinoma: correlation with pathologic findings.

J N Buy1, A A Moss, C Guinet, M A Ghossain, L Malbec, L Arrive, D Vadrot.   

Abstract

Forty patients with bladder carcinoma were examined preoperatively by means of magnetic resonance (MR) imaging. In all patients, total cystectomy with enterocystoplasty and pelvic node dissection was performed. The surgical and pathologic findings were correlated with the MR findings. Extension through the deep muscle of the bladder wall was present in 20 of the 40 patients and was diagnosed with a sensitivity of 95% and a specificity of 95%. Extension to perivesical fat was present in 18 of 40 patients and was diagnosed with a sensitivity of 66% and a specificity of 100%. Invasion of the adjacent organs was present in nine of 40 patients and was diagnosed with a sensitivity of 44% and a specificity of 96%. On the basis of the MR findings, the tumor was correctly staged, according to the TNM classification, in 24 of 40 (60%) patients, tumor extension was overestimated in three of 40 (7.5%) patients, and tumor extension was underestimated in 13 of 40 (32.5%) patients. MR imaging has been shown to be accurate in identification of macroscopic lymph node involvement and deep muscle involvement. It appears to be at least as useful as computed tomography (CT) in the evaluation of perivesical fat involvement and to be superior to CT in the detection of invasion of adjacent organs. One limitation of MR imaging is in the evaluation of tumor extension into the periurethral glands.

Entities:  

Mesh:

Year:  1988        PMID: 3186994     DOI: 10.1148/radiology.169.3.3186994

Source DB:  PubMed          Journal:  Radiology        ISSN: 0033-8419            Impact factor:   11.105


  13 in total

1.  Magnetic resonance imaging in oncology.

Authors:  J E Husband; R Guy
Journal:  Gut       Date:  1992-12       Impact factor: 23.059

2.  Clinical value of fluorine-18 2-fluoro-2-deoxy-D-glucose positron emission tomography/computed tomography in bladder cancer.

Authors:  Andrea B Apolo; Jamie Riches; Heiko Schöder; Oguz Akin; Alisa Trout; Matthew I Milowsky; Dean F Bajorin
Journal:  J Clin Oncol       Date:  2010-08-02       Impact factor: 44.544

3.  Preliminary assessment of fluorine-18 fluorodeoxyglucose positron emission tomography in patients with bladder cancer.

Authors:  S Kosuda; P V Kison; R Greenough; H B Grossman; R L Wahl
Journal:  Eur J Nucl Med       Date:  1997-06

4.  Diagnostic performance of diffusion-weighted magnetic resonance imaging in bladder cancer: potential utility of apparent diffusion coefficient values as a biomarker to predict clinical aggressiveness.

Authors:  Shuichiro Kobayashi; Fumitaka Koga; Soichiro Yoshida; Hitoshi Masuda; Chikako Ishii; Hiroshi Tanaka; Yoshinobu Komai; Minato Yokoyama; Kazutaka Saito; Yasuhisa Fujii; Satoru Kawakami; Kazunori Kihara
Journal:  Eur Radiol       Date:  2011-06-18       Impact factor: 5.315

Review 5.  [Value of positron emission tomography in urological neoplasms: more form than substance?].

Authors:  J Müller; M Schrader; A J Schrader; M Höpfner; F Zengerling
Journal:  Urologe A       Date:  2012-03       Impact factor: 0.639

6.  Role of Dynamic Contrast-Enhanced Magnetic Resonance Imaging in Staging of Bladder Cancer.

Authors:  Elham Rabie; Fariborz Faeghi; Mohammad-Hossein Izadpanahi; Mohammad-Ali Dayani
Journal:  J Clin Diagn Res       Date:  2016-04-01

7.  Prospective study of [18F]fluorodeoxyglucose positron emission tomography/computed tomography for staging of muscle-invasive bladder carcinoma.

Authors:  Adam S Kibel; Farrokh Dehdashti; Matthew D Katz; Aleksandra P Klim; Robert L Grubb; Peter A Humphrey; Cary Siegel; Dengfeng Cao; Feng Gao; Barry A Siegel
Journal:  J Clin Oncol       Date:  2009-08-03       Impact factor: 44.544

Review 8.  Primary staging of urinary bladder carcinoma: the role of MRI and a comparison with CT.

Authors:  J O Barentsz; G J Jager; J A Witjes; J H Ruijs
Journal:  Eur Radiol       Date:  1996       Impact factor: 5.315

9.  Comparison of dynamic contrast-enhanced and diffusion weighted magnetic resonance image in staging and grading of carcinoma bladder with histopathological correlation.

Authors:  Neetika Gupta; Binit Sureka; Mittal Mahesh Kumar; Amita Malik; Thukral Brij Bhushan; N K Mohanty
Journal:  Urol Ann       Date:  2015 Apr-Jun

10.  Neoadjuvant gemcitabine and carboplatin followed by immediate cystectomy may be associated with a survival benefit in patients with clinical T2 bladder cancer.

Authors:  Takuya Koie; Chikara Ohyama; Hayato Yamamoto; Atsushi Imai; Shingo Hatakeyama; Takahiro Yoneyama; Yasuhiro Hashimoto; Tohru Yoneyama; Yuki Tobisawa
Journal:  Med Oncol       Date:  2014-04-04       Impact factor: 3.064

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.